{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T11:42:50Z","timestamp":1776166970829,"version":"3.50.1"},"reference-count":63,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100016359","name":"Zhongnan Hospital of Wuhan University","doi-asserted-by":"publisher","award":["PTXM2022017"],"award-info":[{"award-number":["PTXM2022017"]}],"id":[{"id":"10.13039\/501100016359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004330","name":"Smoking Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81272372"],"award-info":[{"award-number":["81272372"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.clbc.2026.01.011","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T16:46:21Z","timestamp":1769013981000},"page":"102-118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Venous Thromboembolism-Associated Model for Predicting Tumor Microenvironment Features in Breast Cancer"],"prefix":"10.1016","volume":"26","author":[{"given":"Zhuoyun","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianqun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinghua","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.clbc.2026.01.011_bib0001","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/s41591-025-03502-3","article-title":"Global patterns and trends in breast cancer incidence and mortality across 185 countries","volume":"31","author":"Kim","year":"2025","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.clbc.2026.01.011_bib0002","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"Suppl 1","key":"10.1016\/j.clbc.2026.01.011_bib0003","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1038\/sj.bjc.6605599","article-title":"Epidemiology and pathophysiology of cancer-associated thrombosis","volume":"102","author":"Noble","year":"2010","journal-title":"Br J Cancer"},{"issue":"14","key":"10.1016\/j.clbc.2026.01.011_bib0004","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1182\/blood.2020007338","article-title":"Venous thromboembolism in cancer patients: a population-based cohort study","volume":"137","author":"Mulder","year":"2021","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.clbc.2026.01.011_bib0005","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/cncr.30364","article-title":"Time-dependent risk and predictors of venous thromboembolism in breast cancer patients: a population-based cohort study","volume":"123","author":"Brand","year":"2017","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.clbc.2026.01.011_bib0006","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-005082","article-title":"Impact of comorbidity on risk of venous thromboembolism in patients with breast cancer: a Danish population-based cohort study","volume":"4","author":"Ording","year":"2014","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.clbc.2026.01.011_bib0007","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1182\/bloodadvances.2021005590","article-title":"The incidence of cancer-associated thrombosis is increasing over time","volume":"6","author":"Mahajan","year":"2022","journal-title":"Blood Adv"},{"issue":"4","key":"10.1016\/j.clbc.2026.01.011_bib0008","doi-asserted-by":"crossref","first-page":"988","DOI":"10.3390\/cancers14040988","article-title":"Incidence and risk factors for venous thromboembolism in female patients undergoing breast surgery","volume":"14","author":"Londero","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"4 Suppl","key":"10.1016\/j.clbc.2026.01.011_bib0009","doi-asserted-by":"crossref","first-page":"S495","DOI":"10.1016\/j.amepre.2009.12.017","article-title":"Venous thromboembolism: a public health concern","volume":"38","author":"Beckman","year":"2010","journal-title":"Am J Prev Med"},{"issue":"25","key":"10.1016\/j.clbc.2026.01.011_bib0010","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1056\/NEJM200012213432504","article-title":"Prognosis of cancers associated with venous thromboembolism","volume":"343","author":"S\u00f8rensen","year":"2000","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.clbc.2026.01.011_bib0011","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1200\/JCO.2006.07.4393","article-title":"Incidence of venous thromboembolism and the impact on survival in breast cancer patients","volume":"25","author":"Chew","year":"2007","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.clbc.2026.01.011_bib0012","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1001\/archinte.165.10.1173","article-title":"Prospective evaluation of health-related quality of life in patients with deep venous thrombosis","volume":"165","author":"Kahn","year":"2005","journal-title":"Arch Intern Med"},{"issue":"15","key":"10.1016\/j.clbc.2026.01.011_bib0013","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1001\/archinte.164.15.1653","article-title":"Outcomes and cost of deep venous thrombosis among patients with cancer","volume":"164","author":"Elting","year":"2004","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1016\/j.clbc.2026.01.011_bib0014","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.jtha.2023.02.029","article-title":"Cancer-associated thrombosis: enhanced awareness and pathophysiologic complexity","volume":"21","author":"Falanga","year":"2023","journal-title":"J Thromb Haemost"},{"issue":"2","key":"10.1016\/j.clbc.2026.01.011_bib0015","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/jth.12075","article-title":"Coagulation and cancer: biological and clinical aspects","volume":"11","author":"Falanga","year":"2013","journal-title":"J Thromb Haemost"},{"issue":"2","key":"10.1016\/j.clbc.2026.01.011_bib0016","first-page":"399","article-title":"Activation of coagulation and angiogenesis in cancer: immunohistochemical localization in situ of clotting proteins and vascular endothelial growth factor in human cancer","volume":"152","author":"Shoji","year":"1998","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.clbc.2026.01.011_bib0017","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1055\/s-2004-822969","article-title":"Tissue factor and fibrin in tumor angiogenesis","volume":"30","author":"Fernandez","year":"2004","journal-title":"Semin Thromb Hemost"},{"issue":"D1","key":"10.1016\/j.clbc.2026.01.011_bib0018","doi-asserted-by":"crossref","first-page":"D138","DOI":"10.1093\/nar\/gkad965","article-title":"NCBI GEO: archive for gene expression and epigenomics data sets: 23-year update","volume":"52","author":"Clough","year":"2024","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/j.clbc.2026.01.011_bib0019","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s43556-024-00197-9","article-title":"Pan-cancer analysis identifies venous thromboembolism-related genes F3, PLAT, and C1S as potential prognostic biomarkers for glioblastoma and lower grade glioma","volume":"5","author":"Zhang","year":"2024","journal-title":"Mol Biomed"},{"issue":"1","key":"10.1016\/j.clbc.2026.01.011_bib0020","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1089\/omi.2009.0083","article-title":"ConsensusCluster: a software tool for unsupervised cluster discovery in numerical data","volume":"14","author":"Seiler","year":"2010","journal-title":"Omics"},{"issue":"1","key":"10.1016\/j.clbc.2026.01.011_bib0021","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","article-title":"Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade","volume":"18","author":"Charoentong","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.clbc.2026.01.011_bib0022","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinformatics"},{"issue":"6","key":"10.1016\/j.clbc.2026.01.011_bib0023","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst"},{"issue":"27","key":"10.1016\/j.clbc.2026.01.011_bib0024","doi-asserted-by":"crossref","first-page":"7383","DOI":"10.1073\/pnas.1510506113","article-title":"Lasso adjustments of treatment effect estimates in randomized experiments","volume":"113","author":"Bloniarz","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"10.1016\/j.clbc.2026.01.011_bib0025","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1101\/gr.239244.118","article-title":"Maftools: efficient and comprehensive analysis of somatic variants in cancer","volume":"28","author":"Mayakonda","year":"2018","journal-title":"Genome Res"},{"issue":"9","key":"10.1016\/j.clbc.2026.01.011_bib0026","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107468","article-title":"pRRophetic: an R package for prediction of clinical chemotherapeutic response from tumor gene expression levels","volume":"9","author":"Geeleher","year":"2014","journal-title":"PLoS One"},{"issue":"6352","key":"10.1016\/j.clbc.2026.01.011_bib0027","doi-asserted-by":"crossref","first-page":"eaan2507","DOI":"10.1126\/science.aan2507","article-title":"A pathology atlas of the human cancer transcriptome","volume":"357","author":"Uhlen","year":"2017","journal-title":"Science"},{"issue":"20 Suppl","key":"10.1016\/j.clbc.2026.01.011_bib0028","first-page":"S376","article-title":"Overview of venous thromboembolism","volume":"23","author":"Phillippe","year":"2017","journal-title":"Am J Manag Care"},{"issue":"Suppl 2","key":"10.1016\/j.clbc.2026.01.011_bib0029","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1016\/S0049-3848(14)50013-8","article-title":"Effects of tumor-expressed coagulation factors on cancer progression and venous thrombosis: is there a key factor?","volume":"133","author":"\u00dcnl\u00fc","year":"2014","journal-title":"Thromb Res"},{"issue":"11","key":"10.1016\/j.clbc.2026.01.011_bib0030","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1182\/blood-2013-04-460139","article-title":"Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients","volume":"122","author":"Geddings","year":"2013","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1016\/j.clbc.2026.01.011_bib0031","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/S0049-3848(16)30094-9","article-title":"Microparticles and cancer thrombosis in animal models","volume":"140","author":"Mege","year":"2016","journal-title":"Thromb Res"},{"issue":"Suppl 1","key":"10.1016\/j.clbc.2026.01.011_bib0032","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1007\/s10875-012-9847-0","article-title":"Cancer-related inflammation","volume":"33","author":"Candido","year":"2013","journal-title":"J Clin Immunol"},{"issue":"1","key":"10.1016\/j.clbc.2026.01.011_bib0033","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.semcancer.2011.12.005","article-title":"Cancer-related inflammation: common themes and therapeutic opportunities","volume":"22","author":"Balkwill","year":"2012","journal-title":"Semin Cancer Biol"},{"issue":"2","key":"10.1016\/j.clbc.2026.01.011_bib0034","first-page":"83","article-title":"Alpha-1 antitrypsin blood levels as indicator for the efficacy of cancer treatment","volume":"4","author":"El-Akawi","year":"2013","journal-title":"World J Oncol"},{"issue":"14","key":"10.1016\/j.clbc.2026.01.011_bib0035","doi-asserted-by":"crossref","first-page":"11566","DOI":"10.3390\/ijms241411566","article-title":"Serpin Family A member 1 is prognostic and involved in immunological regulation in human cancers","volume":"24","author":"Kuai","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.clbc.2026.01.011_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121938","article-title":"Identification of Serpin peptidase inhibitor clade A member 1 (SERPINA1) might be a poor prognosis biomarker promoting the progression of papillary thyroid cancer","volume":"329","author":"Li","year":"2023","journal-title":"Life Sci"},{"issue":"1","key":"10.1016\/j.clbc.2026.01.011_bib0037","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13148-025-01891-3","article-title":"SERPINA1 methylation as a novel diagnostic marker for early-stage papillary thyroid carcinoma via MAPK6-AKT\/mTOR pathway","volume":"17","author":"Li","year":"2025","journal-title":"Clin Epigenetics"},{"issue":"2","key":"10.1016\/j.clbc.2026.01.011_bib0038","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/JTO.0b013e31820213fb","article-title":"Alpha1-antitrypsin deficiency carriers, serum alpha 1-antitrypsin concentration, and non-small cell lung cancer survival","volume":"6","author":"Li","year":"2011","journal-title":"J Thorac Oncol"},{"issue":"11","key":"10.1016\/j.clbc.2026.01.011_bib0039","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1074\/mcp.M112.017384","article-title":"Secretomic analysis identifies alpha-1 antitrypsin (A1AT) as a required protein in cancer cell migration, invasion, and pericellular fibronectin assembly for facilitating lung colonization of lung adenocarcinoma cells","volume":"11","author":"Chang","year":"2012","journal-title":"Mol Cell Proteomics"},{"issue":"4","key":"10.1016\/j.clbc.2026.01.011_bib0040","first-page":"637","article-title":"Prognosis and lung-cancer - the contribution of plasma-proteins","volume":"2","author":"Ferrigno","year":"1995","journal-title":"Oncol Rep"},{"key":"10.1016\/j.clbc.2026.01.011_bib0041","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.2147\/OTT.S242579","article-title":"Alpha-1 antitrypsin induces epithelial-to-mesenchymal transition, endothelial-to-mesenchymal transition, and drug resistance in lung cancer cells","volume":"13","author":"Wu","year":"2020","journal-title":"Onco Targets Ther"},{"issue":"10","key":"10.1016\/j.clbc.2026.01.011_bib0042","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0046-8177(84)80125-2","article-title":"Alpha 1-antitrypsin, alpha 1-antichymotrypsin, and alpha 2-macroglobulin in human gastric carcinomas: a retrospective immunohistochemical study","volume":"15","author":"Tahara","year":"1984","journal-title":"Hum Pathol"},{"issue":"2","key":"10.1016\/j.clbc.2026.01.011_bib0043","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/ijc.2910450207","article-title":"Prognostic significance of alpha-1-antitrypsin in early stage of colorectal carcinomas","volume":"45","author":"Karashima","year":"1990","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/j.clbc.2026.01.011_bib0044","first-page":"745","article-title":"Alpha 1-antitrypsin blocks the release of transforming growth factor-alpha from MCF-7 human breast cancer cells","volume":"82","author":"Yavelow","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"issue":"28","key":"10.1016\/j.clbc.2026.01.011_bib0045","doi-asserted-by":"crossref","first-page":"25815","DOI":"10.18632\/oncotarget.4441","article-title":"SERPINA1 is a direct estrogen receptor target gene and a predictor of survival in breast cancer patients","volume":"6","author":"Chan","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.clbc.2026.01.011_bib0046","article-title":"Single-cell RNA sequencing reveals tumor immune microenvironment in human hypopharygeal squamous cell carcinoma and lymphatic metastasis","volume":"14","author":"Li","year":"2023","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.clbc.2026.01.011_bib0047","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/bjc.1977.230","article-title":"Prognostic value of serum levels of immunoglobulins (IgG, IgA, IgM and IgE) in breast cancer: a preliminary study","volume":"36","author":"Pettingale","year":"1977","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.clbc.2026.01.011_bib0048","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/art.38194","article-title":"The plasma cell signature in autoimmune disease","volume":"66","author":"Streicher","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.clbc.2026.01.011_bib0049","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1168884","article-title":"Editorial: tumor-promoting immune cells: cancer immune escape and beyond","volume":"14","author":"Domblides","year":"2023","journal-title":"Front Immunol"},{"issue":"12","key":"10.1016\/j.clbc.2026.01.011_bib0050","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1016\/j.immuni.2021.11.015","article-title":"Cytotoxic CD4(+) T cells in cancer: expanding the immune effector toolbox","volume":"54","author":"Oh","year":"2021","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.clbc.2026.01.011_bib0051","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.trecan.2022.12.007","article-title":"T follicular helper cells in cancer","volume":"9","author":"Guti\u00e9rrez-Melo","year":"2023","journal-title":"Trends Cancer"},{"key":"10.1016\/j.clbc.2026.01.011_bib0052","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1146\/annurev-immunol-101220-015603","article-title":"B cell function in the tumor microenvironment","volume":"40","author":"Downs-Canner","year":"2022","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.clbc.2026.01.011_bib0053","article-title":"Shaping polarization of tumor-associated macrophages In cancer immunotherapy","volume":"13","author":"Gao","year":"2022","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.clbc.2026.01.011_bib0054","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/ni1165","article-title":"Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4","volume":"6","author":"Probst","year":"2005","journal-title":"Nat Immunol"},{"issue":"5","key":"10.1016\/j.clbc.2026.01.011_bib0055","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S1074-7613(03)00120-1","article-title":"Inducible transgenic mice reveal resting dendritic cells as potent inducers of CD8+ T cell tolerance","volume":"18","author":"Probst","year":"2003","journal-title":"Immunity"},{"issue":"11","key":"10.1016\/j.clbc.2026.01.011_bib0056","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.trecan.2022.06.008","article-title":"Therapeutic targeting of regulatory T cells in cancer","volume":"8","author":"Shan","year":"2022","journal-title":"Trends Cancer"},{"issue":"3","key":"10.1016\/j.clbc.2026.01.011_bib0057","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/exd.14721","article-title":"Significance of regulatory T cells in cancer immunology and immunotherapy","volume":"32","author":"Sugiyama","year":"2023","journal-title":"Exp Dermatol"},{"issue":"5","key":"10.1016\/j.clbc.2026.01.011_bib0058","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1182\/blood.2019000919","article-title":"Novel antithrombotic strategies for treatment of venous thromboembolism","volume":"135","author":"Weitz","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.clbc.2026.01.011_bib0059","doi-asserted-by":"crossref","first-page":"9","DOI":"10.21037\/tbcr-24-15","article-title":"Expert consensus on the clinical application of immunotherapy in breast cancer: 2024","volume":"5","author":"Wang","year":"2024","journal-title":"Transl Breast Cancer Res"},{"key":"10.1016\/j.clbc.2026.01.011_bib0060","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0074-7696(07)56005-5","article-title":"MHC class I antigens and immune surveillance in transformed cells","volume":"256","author":"Aptsiauri","year":"2007","journal-title":"Int Rev Cytol"},{"key":"10.1016\/j.clbc.2026.01.011_bib0061","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115209","article-title":"Targeted therapy for breast cancer: an overview of drug classes and outcomes","volume":"204","author":"Jacobs","year":"2022","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"10.1016\/j.clbc.2026.01.011_bib0062","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.soc.2013.06.008","article-title":"Targeting the PI3-kinase\/Akt\/mTOR signaling pathway","volume":"22","author":"Hassan","year":"2013","journal-title":"Surg Oncol Clin N Am"},{"issue":"1","key":"10.1016\/j.clbc.2026.01.011_bib0063","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","article-title":"PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer","volume":"22","author":"Glaviano","year":"2023","journal-title":"Mol Cancer"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152682092600011X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152682092600011X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T10:39:28Z","timestamp":1776163168000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152682092600011X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":63,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S152682092600011X"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2026.01.011","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Venous Thromboembolism-Associated Model for Predicting Tumor Microenvironment Features in Breast Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2026.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}